Gabriele Fontana

Azacitidine maintenance after allogeneic hematopoietic stem cell transplantation in high-risk AML: a single-center retrospective study

In patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), disease relapse remains the leading cause of transplant failure [ 1 ]. Growing evidence indicates that immune escape represents a major mechanism driving post-...